- $22.87m
- $32.64m
- $177.93m
- 81
- 77
- 24
- 64
Annual income statement for ICZOOM, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS/A | PROSPECTUS/A | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 165 | 279 | 290 | 214 | 178 |
| Cost of Revenue | |||||
| Gross Profit | 4.6 | 8.02 | 7.81 | 5.29 | 4.95 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 164 | 276 | 287 | 214 | 179 |
| Operating Profit | 0.976 | 3.4 | 3.17 | 0.875 | -1.34 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 1.31 | 3.7 | 3.16 | 2.02 | -2.34 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.592 | 2.63 | 2.57 | 1.75 | -2.27 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.592 | 2.63 | 2.57 | 1.75 | -2.27 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.592 | 2.63 | 2.57 | 1.75 | -2.27 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.057 | 0.255 | 0.265 | 0.177 | -0.218 |
| Dividends per Share |